An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.
Experimental Treatment Gaining Traction Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts privately for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting products of unknown origin.
Some experts said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or prison.
Service Response and Material Elimination
Based on TikTok, the platform has taken down violative material and banned associated keywords and search suggestions. The company stated it was dedicated to keeping the service secure and investing in enhancing compliance measures.
Online Trading Operations
Research also found communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, positive reviews and detailed guides for preparing or administering at residence.
Within moments of entering one group, a vendor posted contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.
Product Details and Pricing
Inside these groups, messages show black plastic parcels with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram stated it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to potentially serious health risks”.
